In conclusion, this study identifies dysregulated sphingolipid metabolism, particularly SPHK1-S1p signaling, as a central mechanism driving fibrocyte recruitment and activation in pulmonary fibrosis. The gene discussed is SPHK1; the disease is pulmonary fibrosis.